David Casadevall

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Joana Vidal, David Casadevall, Beatríz Bellosillo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Surgery +17

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples

David Casadevall, Sergi Clavé, Álvaro Taus et al. · Clinical Lung Cancer · 2017 · 85 citations

Medicine, Immunology, Oncology +16

Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women

Tess A. O’Meara, Anton Safonov, David Casadevall et al. · Breast Cancer Research and Treatment · 2019 · 66 citations · Full text

Medicine, Immunology, Oncology +16

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque et al. · Nature Cancer · 2022 · 64 citations · Full text

Life Sciences, Immunology, Oncology +16

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

David Casadevall, Javier Gimeno, Sergi Clavé et al. · Oncotarget · 2015 · 58 citations · Full text

Medicine, Molecular Genetics, Oncology +17